Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial

Line Uhrenholt(Aalborg University Hospital), Salome Kristensen(Aalborg University Hospital)

British Journal of Clinical Pharmacology

June 6, 2023

10.1111/bcp.15806

Cited by 7

Related Papers

Increased risk of cardiovascular disease preceding diagnosis of incident ANCA-associated vasculitis: a Danish nationwide study

|Lara D. Veeken|2023|24

Long-term cardiovascular outcomes and temporal trends in patients diagnosed with ANCA-associated vasculitis: a Danish nationwide registry study

|Lara D. Veeken|2022|20